Co-morbidities and clinically relevant drug-drug interactions (DDIs) in patients undergoing treatment of chronic HCV genotype 1 (GT1) infection with elbasvir (EBR)/grazoprevir (GZR): results from the German Hepatitis C Registry (DHC-R)

HEPATOLOGY(2017)

引用 0|浏览7
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要